|
US6224903B1
|
|
Polymer-lipid conjugate for fusion of target membranes
|
|
US6133026A
|
|
Condensed plasmid-liposome complex for transfection
|
|
US6056973A
|
|
Therapeutic liposome composition and method of preparation
|
|
TWI225412B
|
|
Liposome-entrapped polynucleotide composition and method
|
|
US5972379A
|
|
Liposome composition and method for administering a quinolone
|
|
EP1214935A2
|
|
Fusogenic liposome composition and method
|
|
AU4907897A
|
|
Therapeutic liposome composition and method
|
|
TW520297B
|
|
Fusogenic liposome composition and method
|
|
AU3985697A
|
|
Liposomes containing a cisplatin compound
|
|
US5851818A
|
|
Condensed plasmid-liposome complex for transfection
|
|
AU4981896A
|
|
Liposome composition and method for administering liposome-loadable drugs
|
|
US6180134B1
|
|
Enhanced ciruclation effector composition and method
|
|
US5527528A
|
|
Solid-tumor treatment method
|
|
US6326353B1
|
|
Enhanced circulation effector composition and method
|
|
US5843473A
|
|
Method of treatment of infected tissues
|
